O'Brien K O, Zavaleta N, Caulfield L E, Yang D X, Abrams S A
Center for Human Nutrition, The Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205, USA.
Am J Clin Nutr. 1999 Mar;69(3):509-15. doi: 10.1093/ajcn/69.3.509.
It is estimated that 60% of pregnant women worldwide are anemic.
We aimed to examine the influence of iron status on iron absorption during pregnancy by measuring supplemental iron absorption, red blood cell iron incorporation, and iron status in pregnant women.
Subjects were 45 pregnant Peruvian women (33+/-1 wk gestation), of whom 28 received daily prenatal supplements containing 60 mg Fe and 250 microg folate without (Fe group, n = 14) or with (Fe+Zn group, n = 14) 15 mg Zn, which were were consumed from week 10 to 24 of gestation until delivery. The remaining 17 women (control) received no prenatal supplementation. Iron status indicators and isotopes were measured in maternal blood collected 2 wk postdosing with oral (57Fe) and intravenous (58Fe) stable iron isotopes.
Maternal serum ferritin and folate concentrations were significantly influenced by supplementation (P < 0.05). Serum iron was also significantly higher in the Fe than in the Fe+Zn (P < 0.03) or control (P < 0.001) groups. However, the supplemented groups had significantly lower serum zinc concentrations than the control group (8.4+/-2.3 and 10.9+/-1.8 micromol/L, respectively, P < 0.01). Although percentage iron absorption was inversely related to maternal serum ferritin concentrations (P = 0.036), this effect was limited and percentage iron absorption did not differ significantly between groups.
Because absorption of nonheme iron was not substantially greater in pregnant women with depleted iron reserves, prenatal iron supplementation is important for meeting iron requirements during pregnancy.
据估计,全球60%的孕妇患有贫血。
我们旨在通过测量孕妇补充铁的吸收、红细胞铁掺入和铁状态,来研究孕期铁状态对铁吸收的影响。
研究对象为45名秘鲁孕妇(妊娠33±1周),其中28名孕妇从妊娠第10周开始至第24周每天服用含60毫克铁和250微克叶酸的产前补充剂,其中14名孕妇(铁组,n = 14)服用的补充剂不含锌,另外14名孕妇(铁+锌组,n = 14)服用的补充剂含15毫克锌,直至分娩。其余17名女性(对照组)未接受产前补充剂。在口服(57Fe)和静脉注射(58Fe)稳定铁同位素给药2周后采集的母体血液中测量铁状态指标和同位素。
补充剂对母体血清铁蛋白和叶酸浓度有显著影响(P < 0.05)。铁组的血清铁也显著高于铁+锌组(P < 0.03)或对照组(P < 0.001)。然而,补充剂组的血清锌浓度显著低于对照组(分别为8.4±2.3和10.9±1.8微摩尔/升,P < 0.01)。虽然铁吸收百分比与母体血清铁蛋白浓度呈负相关(P = 0.036),但这种影响有限,各组之间的铁吸收百分比无显著差异。
由于铁储备不足的孕妇中非血红素铁的吸收没有显著增加,产前补充铁对满足孕期铁需求很重要。